Higher levels of Casp1p20 and IL-18 which are inflammasome-derived products in the sera were found associated with COVID-19 severity and poor clinical outcome, including IL-6 and lactate dehydrogenase [21]. This evidence concerns the gene IL18 and COVID-19.